Nalmefene Hydrochloride
Payments companies reported to CMS as associated with Nalmefene Hydrochloride. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Nalmefene Hydrochloride, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Nalmefene Hydrochloride
These are the largest totals companies reported as associated with Nalmefene Hydrochloride. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Glen Apseloff | Columbus, OH | $15,955.09 | |
| Jeffrey Galinkin | Aurora, CO | Pediatric Anesthesiology | $10,518.00 |
| David Miramontes | San Antonio, TX | Emergency Medicine | $8,061.99 |
| Michael Gardiner | San Diego, CA | Pediatric Emergency Medicine (Pediatrics) | $6,016.00 |
| Rachael Rzasa-Lynn | Aurora, CO | Pain Medicine (Anesthesiology) | $5,118.00 |
| David Drover | Stanford, CA | Anesthesiology | $4,130.00 |
| John Berkenbosch | Louisville, KY | Pediatric Critical Care Medicine | $3,825.00 |
| Rahul Nene | San Diego, CA | Emergency Medicine | $3,178.00 |
| Justin Seltzer | San Diego, CA | Emergency Medicine | $3,178.00 |
| Christian Tomaszewski | San Diego, CA | Medical Toxicology (Emergency Medicine) | $3,178.00 |
Prescribed Nalmefene Hydrochloride?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.